Cochlear implants for DFNA17 deafness

Laryngoscope. 2006 Dec;116(12):2211-5. doi: 10.1097/01.mlg.0000242089.72880.f8.

Abstract

Background: Nonsyndromic autosomal-dominant, adult-onset sensorineural hearing loss resulting from DFNA17 was described in a single American kindred in 1997, and the causative gene was subsequently identified as MYH9.

Objective: The objective of this study was to report clinical and genetic analyses of an Australian family with nonsyndromic adult-onset sensorineural hearing loss.

Methods: The clinical presentation of the family was detailed and identification of the causative gene was conducted by SNP genotyping and direct sequencing.

Results: Sequence analysis of the MYH9 gene revealed the same missense mutation as in the original DFNA17 family. We are not aware of a link between the two kindreds, making the present one only the second DFNA17 family to be reported.

Conclusions: One important point of clinical relevance is the excellent outcome with cochlear implants in the Australian family compared with a "poor" response in the American family. Thus, cochlear implants should be strongly considered for clinical management of patients with DFNA17 deafness.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Child
  • Cochlear Implantation*
  • Female
  • Genetic Linkage
  • Hearing Loss, Sensorineural / epidemiology
  • Hearing Loss, Sensorineural / genetics*
  • Hearing Loss, Sensorineural / surgery*
  • Humans
  • Male
  • Molecular Motor Proteins / genetics*
  • Mutation, Missense
  • Myosin Heavy Chains / genetics*
  • Pedigree
  • Sequence Analysis, DNA

Substances

  • MYH9 protein, human
  • Molecular Motor Proteins
  • Myosin Heavy Chains